| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.18 | 0.2 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.2 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |